BamSEC and AlphaSense Join Forces
Learn More

Alexion Pharmaceuticals, Inc.

Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.2
from 10-K 1 page Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.6
from S-8 21 pages Amended and Restated Portola Pharmaceuticals, Inc. Inducement Plan Adopted by the Board of Directors: July 9, 2017 Amended and Restated by the Board of Directors: December 14, 2018
12/34/56
EX-4.5
from S-8 28 pages 1. General. (A) Eligible Award Recipients. Employees, Directors and Consultants Are Eligible to Receive Awards
12/34/56
EX-4.2
from 10-K 1 page Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.5
from S-8 POS 13 pages Alexion Pharmaceuticals, Inc. 2017 Incentive Plan
12/34/56
EX-4.5
from S-8 POS 13 pages Alexion Pharmaceuticals, Inc. 2017 Incentive Plan
12/34/56
EX-4.5
from S-8 POS 13 pages Alexion Pharmaceuticals, Inc. 2017 Incentive Plan
12/34/56
EX-4.5
from S-8 POS 13 pages Alexion Pharmaceuticals, Inc. 2017 Incentive Plan
12/34/56
EX-4.5
from S-8 13 pages Alexion Pharmaceuticals, Inc. 2017 Incentive Plan
12/34/56
EX-4.5
from S-8 POS 13 pages Alexion Pharmaceuticals, Inc. 2017 Incentive Plan
12/34/56
EX-4.5
from S-8 14 pages Alexion Pharmaceuticals, Inc. 2015 Employee Stock Purchase Plan
12/34/56
EX-4.7
from S-8 POS 17 pages Synageva Biopharma Corp. 2014 Equity Incentive Plan
12/34/56
EX-4.2
from 8-K 12 pages Voting and Support Agreement
12/34/56
EX-4.2
from 425 12 pages Voting and Support Agreement
12/34/56
EX-4.1
from 8-K 16 pages Voting and Support Agreement
12/34/56
EX-4.1
from 425 16 pages Voting and Support Agreement
12/34/56
EX-4.1
from 8-K 3 pages Amendment No. 5 to Rights Agreement
12/34/56
EX-4.10
from 10-K 1 page Amendment No. 4 to Rights Agreement
12/34/56
EX-4.2
from 8-K 25 pages Registration Rights Agreement Dated as of January 25, 2005 Between Alexion Pharmaceuticals, Inc. and Morgan Stanley & Co. Incorporated, Bear, Stearns & Co. Inc., Sg Cowen & Co., LLC and J.P. Morgan Securities Inc
12/34/56
EX-4.1
from 8-K 93 pages Alexion Pharmaceuticals, Inc. to U.S. Bank National Association, as Trustee Indenture Dated as of January 25, 2005 1.375% Convertible Senior Notes Due 2012
12/34/56